Transforming Ophthalmology with Precision Medicine

Character Bio is a precision medicine company unlocking the patterns of progressive polygenic eye diseases, with an initial focus on dry age-related macular degeneration (AMD). Dry AMD impacts one in eight people over the age of fifty and is a leading cause of blindness globally, yet there are limited effective treatment options available.

Character leverages its proprietary genetic, imaging, and clinical database to understand disease progression to develop targeted therapies for patients.